2005
DOI: 10.1001/archderm.141.12.1507
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Gabapentin in the Management of Pruritus of Unknown Origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
57
0
4

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 90 publications
(62 citation statements)
references
References 24 publications
0
57
0
4
Order By: Relevance
“…8,9 Several case reports 8,[10][11][12] document the successful use of gabapentin at varying dosages (range, 100 mg 3 times daily to 300 mg every 4 hours) for brachioradial pruritus. Although the mechanism of action of gabapentin is unknown, it affects neurotransmitters; specifically, it inhibits glutamate synthesis and increases the transmission of ␥-aminobutyric acid.…”
Section: Commentmentioning
confidence: 99%
“…8,9 Several case reports 8,[10][11][12] document the successful use of gabapentin at varying dosages (range, 100 mg 3 times daily to 300 mg every 4 hours) for brachioradial pruritus. Although the mechanism of action of gabapentin is unknown, it affects neurotransmitters; specifically, it inhibits glutamate synthesis and increases the transmission of ␥-aminobutyric acid.…”
Section: Commentmentioning
confidence: 99%
“…Actually, some clinical studies have already demonstrated antipruritic effects of gabapentin and pregabalin. [67][68][69][70] …”
Section: Neuropathic Itchmentioning
confidence: 99%
“…These synapses in the superficial laminae of the dorsal horn at the spinal level transmit signals via interneurons through the anterolateral spinothalamic tract. Supraspinal processing is in the anterior cingulate cortex, supplementary motor area and inferior parietal lobe, with a left hemisphere dominance [7,11,24].…”
Section: Pathophysiology Of Itch Sensationmentioning
confidence: 99%
“…Its efficacy in relieving all kinds of pruritus has now been reported [2,[10][11][12][13]. Its efficacy and safety in paediatric patients have been studied in epilepsy (given in doses of 20-30 mg kg −1 day −1 [14,15], up to a maximum of 40 mg kg −1 day −1 for refractory epilepsy [16]).…”
Section: Introductionmentioning
confidence: 99%